metricas
covid
Buscar en
Atención Primaria
Toda la web
Inicio Atención Primaria Bases fisiopatológicas de la obesidad
Información de la revista
Vol. 25. Núm. 6.
Páginas 425-431 (enero 1999)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 25. Núm. 6.
Páginas 425-431 (enero 1999)
Acceso a texto completo
Bases fisiopatológicas de la obesidad
Visitas
5302
G. Martínez, E. Jódar, F. Hawkins
Servicio de Endocrinología y Nutrición. Hospital Universitario 12 de octubre. Madrid
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.J. Kuczmarski, K.M. Flegal, S.M. Campbell, C.L. Johnson.
Increasing prevalence of overweight among US adults.
JAMA, 272 (1994), pp. 205-211
[2.]
J. Aranceta.
Epidemiología de la obesidad en los países desarrollados.
Nutrición y Obesidad, 1 (1998), pp. 12-22
[3.]
J.C. Eidell.
Obesity in Europe: scaling an epidemic.
Int J Obes, (1995), pp. 1-4
[4.]
S.M. Grundy.
Multifactorial causation of obesity: implications for prevention.
Am J Clin Nutr, 67 (1998), pp. 563-572
[5.]
M. Rosenbaum, R.L. Leibel, J. Hirsch.
Medical progress: obesity.
N Engl J Med, 337 (1997), pp. 396-407
[6.]
A.B. Steffens, J.H. Strubbe, B. Balkan, J.W. Scheurink.
Neuroendocrine mechanisms involved in regulation of body weight, food intake, and metabolism.
Neurosci Biobehav Rev, 14 (1990), pp. 305-313
[7.]
S.F. Leibowitz.
Brain peptides and obesity: pharmacologic treatment.
Obes Res, 3 (1995), pp. 573-589
[8.]
J.E. Blundell.
Serotonin and appetite.
Neuropharmacology, 23 (1984), pp. 1537-1551
[9.]
J.E. Blundell.
Serotonin and the biology of feeding.
Am J Clin Nutr, 55 (1992), pp. 155-159
[10.]
J.J. Wurtman, R.J. Wurtman, J.H. Growden.
Carbohydrate craving in obese people: suppresions by treatments affecting serotonergic transmission.
Int Eat Disord, 1 (1981), pp. 2
[11.]
C.J. Billington, J.E. Briggs, M. Grace, et al.
Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.
Am J Physiol, 260 (1991), pp. 321-327
[12.]
T.W. Stephens, M. Basinski, P.K. Bristow, et al.
A role for neuropeptide Y in the antiobesity action of the obese gene product.
Nature, 377 (1995), pp. 530-532
[13.]
N. Rothwell.
Central effects of CRF on metabolism and energy balance.
Neurosci Biobehav Rev, 14 (1989), pp. 263-271
[14.]
M. Spina, E. Merlo-Pich, R.K. Chan, et al.
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.
Science, 273 (1996), pp. 1561-1564
[15.]
M.D. Turton, D. O’Shea, I. Gunn, et al.
A role for glucagon-like peptide-1 in the central regulation of feeding.
Nature, 273 (1996), pp. 69-72
[16.]
J. Garlicki, P.K. Konturek, J. Majka, et al.
Cholecystokinin receptors and vagal nerves in control of food intake in rats.
Am J Physiol, 258 (1990), pp. 40-45
[17.]
M.W. Scwartz, D.P. Figlewicz, D.P. Baskin, S.C. Woods, D. Porte Jr..
Insulin in the brain: a hormonal regulator of energy balance.
Endocr Rev, 13 (1992), pp. 387-414
[18.]
R.V. Considine, M. Sinha, M. Heiman, et al.
Serum immunoreactive leptin concentrations in normal weight and obese humans.
N Engl J Med, 334 (1995), pp. 292-295
[19.]
Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman.
Positional cloning of the mouse obese gene and its human homologue.
Nature, 372 (1994), pp. 425-432
[20.]
L.A. Campfield, F.J. Smith, Y. Guisez, R. Devos, P. Burn.
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.
Science, 269 (1995), pp. 546-549
[21.]
M.A. Pelleymounter, M. Cullen, M.J. Baker, et al.
Effects of the obese gene product on body weight regulation in ob/ob mice.
Science, 269 (1995), pp. 540-543
[22.]
M.W. Schwartz, D.G. Baskin, T.R. Bukowski, et al.
Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
Diabetes, 45 (1996), pp. 531-535
[23.]
F.F. Chehab, K. Mounzih, R. Lu, M.E. Lim.
Early onset of reproductive function in normal female mice treated with leptin.
Science, 275 (1997), pp. 88-90
[24.]
I. Romieu, W.C. Willet, M.J. Stampfer, et al.
Energy intake and other determinants of relative weight.
Am J Clin Nutr, 47 (1988), pp. 406-412
[25.]
L.G. Bandini, D.A. Schoeller, H. Cyr, et al.
Validity of reported intake in obese and non-obese adolescents.
Am J Clin Nutr, 52 (1990), pp. 421-425
[26.]
A.M. Prentice, A.E. Black, W.A. Coward.
High levels of energy expenditure in obese women.
BMJ, 292 (1986), pp. 983-987
[27.]
M. Rosenbaum, M. Nicolson, J. Hirsch, et al.
Effects of gender, body composition, and menopause on plasma concentrations of leptin.
J Clin Endocrinol Metab, 81 (1996), pp. 3424-3427
[28.]
J.F. Caro, J.W. Kolaczynski, M.R. Nyce, et al.
Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.
Lancet, 348 (1996), pp. 159-161
[29.]
E. Ravussin, B.A. Swinburn.
Pathophysiology of obesity.
Lancet, 340 (1992), pp. 404-408
[30.]
S. Blaza, J.S. Garrow.
Thermogenic response to temperature, exercise and food stimuli in lean and obese women, studied by 24-h direct calorimetry.
Br J Nutr, 49 (1983), pp. 171-180
[31.]
L. Leibel, M. Rosenbaum, J. Hirsch.
Changes in energy expenditure resulting from altered body weight.
N Engl J Med, 332 (1995), pp. 621-628
[32.]
J.W. Kolaczynski, R.V. Considine, J. Ohannesian, et al.
Responses of leptin to shortterm fasting and refeeding in humans.
Diabetes, 45 (1996), pp. 1511-1515
[33.]
A. Astrup, B. Buemann, S. Toubro, et al.
Low resting metabolic rate in subjects predisposed to obesity: a role for thyroid status.
Am J Clin Nutr, 63 (1996), pp. 879-883
[34.]
S.M. Garn, D.C. Clark.
Trends in fatness and the origins of obesity.
Pediatrics, 57 (1976), pp. 443-456
[35.]
M. Visser, P. Deurenberg, W.A. Van Staveren, J.G.A.J. Hautvast.
Resting metabolic rate and diet-induced thermogenesis in young and elderly subjects: relationship with body composition, fat distribution, and physical activity level.
Am J Clin Nutr, 61 (1995), pp. 772-778
[36.]
R.J. Garrison, W.B. Kannel.
A new approach for estimating healthy body weights.
Int J Obes, 17 (1993), pp. 417-423
[37.]
E.T. Poehlman.
Regulation of energy expenditure in aging humans.
J Am Geriatr Soc, 41 (1993), pp. 552-559
[38.]
R.P. Troiano, K.M. Flegal, R.J. Juczmarski, S.M. Campbell, C.L. Johnson.
Overweight prevalence and trends in children and adolescents: the National Health and Nutrition Examination Surveys, 1963-1991.
Arch Pediatr Adolesc Med, 149 (1995), pp. 1085-1091
[39.]
A.J. Stunkard, J.R. Harris, N.L. Pedersen, et al.
The body-mass index of twins who have been reared apart.
N Engl J Med, 322 (1990), pp. 1483-1487
[40.]
P.G. Kopelman, N. Finer, K.R. Fox, A. Hill, I.A. MacDonald.
ASO consensus statement on obesity.
Int J Obesity, 18 (1994), pp. 189-191
[41.]
C. Bouchard, L. Perusse.
Genetics of obesity.
Annu Rev Nutr, 13 (1993), pp. 337-354
[42.]
R. Heller, R.J. Garrison, R.J. Havlik, M. Feinleib, S. Padget.
Family resemblances in height and relative weight in the Framinghan Heart Study.
Int J Obes, 8 (1984), pp. 399-403
[43.]
C. Bouchard, L. Perusse, C. Leblanc, A. Tremblay, G. Theriault.
In heritance of the amount and distribution of human body fat.
In J Obesity, 12 (1988), pp. 205-215
[44.]
A.J. Stunkard, T.I.A. Sorensen, C. Hanis, et al.
An adoption study of human obesity.
N Engl J Med, 314 (1986), pp. 193-198
[45.]
T. Webb, D. Clarke, C.A. Hardy.
A clinical, cytogenetic and molecular study of 40 adults with the Prader-Willi syndrome.
J Med Genet, 32 (1995), pp. 181-185
[46.]
N. Latruffe, J. Vamecq.
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Biochimie, 79 (1997), pp. 81-94
[47.]
C.J. Fleury, M. Neverova, S. Collins, et al.
Uncoupling protein-2: a novel linked to obesity and hyperinsulinemia.
Nat Genet, 15 (1997), pp. 269-272
[48.]
R. Considine, E. Considine, C. Williams, et al.
Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity.
J Clin Invest, 95 (1995), pp. 2986-2988
[49.]
R.V. Considine, E.L. Considine, C.J. Williams, et al.
The hypothalamic leptin receptor in humans.
Diabetes, 19 (1996), pp. 992-994
[50.]
C.T. Montague, I.S. Farooqi, J.P. Whitehead, et al.
Congenital leptin deficiency is associated with severe early-onset obesity in humans.
Nature, 387 (1997), pp. 903-908
[51.]
K. Clement, C. Vaisse, N. Lahlou, et al.
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.
Nature, 392 (1998), pp. 398-401
[52.]
K. Clement, C. Vaisse, B.S.J. Manning, et al.
Genetic variation in the β-3 adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.
N Engl J Med, 333 (1995), pp. 352-354
[53.]
J. Walston, K. Silver, C. Bogardus, et al.
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β-3 adrenergic receptor gene.
N Engl J Med, 333 (1995), pp. 343-347
[54.]
E. Widen, M. Lehto, T. Kanninen, et al.
Association of a polymorphism in the β-3 adrenergic receptor gene with features of the insulin resistance syndrome in Finns.
N Engl J Med, 333 (1995), pp. 348-351
[55.]
M. Ristow, D. Muller-Wieland, A. Pfeiffer, W. Krone, C.R. Kahn.
Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.
N Engl J Med, 339 (1998), pp. 953-959
[56.]
J.V. Neel.
Diabetes mellitus: a thrighty genotype rendered detrimental by progress.
Am J Hum Genet, 14 (1962), pp. 353-362
[57.]
E. Ravussin, M.E. Valencia, J. Esparza, P.H. Bennett, L.O. Schulz.
Effects of a traditional lifestyle on obesity in Pima Indians.
Diabetes Care, 17 (1994), pp. 1067-1074
[58.]
W.C. Willett.
Is dietary fat a major determinant of body fat?.
Am J Clin Nutr, 67 (1998), pp. 556-562
[59.]
A. Astrup.
Dietary composition, substrate balances and body fat in subjects with a predisposition to obesity.
Int J Obes, 17 (1993), pp. 32-36
[60.]
E. Ravussin, P.A. Tataranni.
Dietary fat and human obesity.
J Am Diet Assoc, 97 (1997), pp. 42-46
[61.]
H. Kato, J. Tillotson, M.Z. Nichaman, G.G. Rhoads, H.B. Hamilton.
Epidemiologic studies of coronary heart disease end stroke in Japanese men living in Japan, Hawaii, and California.
Am J Epidemiol, 97 (1973), pp. 372-385
[62.]
L. Lissner, B.L. Heitmann.
Dietary fat and obesity: evidence from epidemiology.
Eur J Clin Nutr, 49 (1995), pp. 79-90
[63.]
Centers for Disease Control and Prevention.
Daily dietary fat and total foodenergy intakes: Third National Health and Nutrition Examination Survey, Phase 1, 1988-1991.
MMWR Morbid Mortal Wkly Rep, 43 (1994), pp. 116-117
[64.]
G.A. Colditz, W.C. Willett, M.J. Stampfer, S.J. London, M.R. Segal, F.E. Speizer.
Patterns of weight change and their relation to diet in a cohort of healthy women.
Am J Clin Nutr, 51 (1990), pp. 1100-1105
[65.]
B.L. Heitmann, L. Lissner, T.I.A. Sorensen, C. Bengtsson.
Dietary fat intake and weight gain in women genetically predisposed for obesity.
Am J Clin Nutr, 61 (1995), pp. 1213-1217
[66.]
J.C. Seidell.
Dietary fat and obesity: an epidemiologic perspective.
Am J Clin Nutr, 67 (1998), pp. 546-550
[67.]
E.J. Schaefer, A.H. Lichtenstein, S. Lamon-Fava, et al.
Body weight and low-density lipoprotein changes after consumption of a low-fat ad libitum diet.
JAMA, 274 (1995), pp. 1450-1455
[68.]
R.W. Jeffery, W.L. Hellerstedt, S.A. French, J.E. Baxter.
A randomized trial of counseling for fat restriction versus caloric restriction in the treatment of obesity.
Int J Obes, 19 (1995), pp. 132-137
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos